Home - Products - Endocrinology/Hormones - AhR - CAY10464

CAY10464

CAS No. 688348-37-0

CAY10464( —— )

Catalog No. M37540 CAS No. 688348-37-0

CAY10464 (AHR antagonist 7) is a potent AHR antagonist with potential antitumor activity that inhibits CYP1A1 mRNA expression and may be used to study cancer and metabolic diseases.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
5MG	38	In Stock
10MG	61	In Stock
25MG	123	In Stock
50MG	198	In Stock
100MG	296	In Stock
200MG	Get Quote	In Stock
500MG	706	In Stock
1G	Get Quote	In Stock

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

CAY10464
Note

Research use only, not for human use.
Brief Description

CAY10464 (AHR antagonist 7) is a potent AHR antagonist with potential antitumor activity that inhibits CYP1A1 mRNA expression and may be used to study cancer and metabolic diseases.
Description

CAY10464 (AHR antagonist 7) is a potent AHR antagonist with potential antitumor activity that inhibits CYP1A1 mRNA expression and may be used to study cancer and metabolic diseases.
In Vitro

——
In Vivo

——
Synonyms

——
Pathway

Endocrinology/Hormones
Target

AhR
Recptor

AhR
Research Area

——
Indication

——

Chemical Information

CAS Number

688348-37-0
Formula Weight

279.16
Molecular Formula

C15H12Cl2O
Purity

>98% (HPLC)
Solubility

——
SMILES

C(=C/C1=CC(Cl)=CC(Cl)=C1)\C2=CC=C(OC)C=C2
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

Nimodipine

Nimodipine(Nimotop) is a dihydropyridine derivative and an analogue of the calcium channel blocker nifedipine, with antihypertensive activity.Nimodipine decreases intracellular free Ca2+,Beclin-1 and autophagy.
TCDD

A potent AHR (aryl hydrocarbon receptor) agonist that induces degradation of AhR by the ubiquitin-proteasome pathway.
AHR Inhibitor I-103

AHR Inhibitor I-103 is an aryl hydrocarbon receptor (AHR) inhibitor with anticancer activity used in the study of breast cancer and acute myeloid leukemia.

Sign In Join Free